144 related articles for article (PubMed ID: 38674046)
1. Promising Approaches in Plant-Based Therapies for Thyroid Cancer: An Overview of In Vitro, In Vivo, and Clinical Trial Studies.
Kaczmarzyk I; Nowak-Perlak M; Woźniak M
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674046
[TBL] [Abstract][Full Text] [Related]
2. Plant natural products with anti-thyroid cancer activity.
Sharifi-Rad J; Rajabi S; Martorell M; López MD; Toro MT; Barollo S; Armanini D; Fokou PVT; Zagotto G; Ribaudo G; Pezzani R
Fitoterapia; 2020 Oct; 146():104640. PubMed ID: 32474055
[TBL] [Abstract][Full Text] [Related]
3. Antitumor Effect of Various Phytochemicals on Diverse Types of Thyroid Cancers.
Shin HJ; Hwang KA; Choi KC
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30634497
[TBL] [Abstract][Full Text] [Related]
4. Effects of nutraceuticals on anaplastic thyroid cancer cells.
Allegri L; Rosignolo F; Mio C; Filetti S; Baldan F; Damante G
J Cancer Res Clin Oncol; 2018 Feb; 144(2):285-294. PubMed ID: 29197967
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effects of natural phytochemicals in anaplastic thyroid cancer (Review).
Li Y; Zhang J; Zhou H; Du Z
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856443
[TBL] [Abstract][Full Text] [Related]
6. Hypericin-assisted photodynamic therapy against anaplastic thyroid cancer.
Kim H; Kim SW; Seok KH; Hwang CW; Ahn JC; Jin JO; Kang HW
Photodiagnosis Photodyn Ther; 2018 Dec; 24():15-21. PubMed ID: 30118906
[TBL] [Abstract][Full Text] [Related]
7. Ellagic acid inhibits cell proliferation, migration, and invasion of anaplastic thyroid cancer cells via the Wnt/β-catenin and PI3K/Akt pathways.
Meng X; Cui Z; Shi H; Ma X; Li W; Liu X; Jiang Y
Acta Biochim Pol; 2023 Feb; 70(1):109-115. PubMed ID: 36773307
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide and thyroid carcinoma: A review.
Huang Y; Suguro R; Hu W; Zheng J; Liu Y; Guan M; Zhou N; Zhang X
Front Endocrinol (Lausanne); 2022; 13():1050656. PubMed ID: 36699047
[TBL] [Abstract][Full Text] [Related]
9. Molecular features of aggressive thyroid cancer.
Elia G; Patrizio A; Ragusa F; Paparo SR; Mazzi V; Balestri E; Botrini C; Rugani L; Benvenga S; Materazzi G; Spinelli C; Antonelli A; Fallahi P; Ferrari SM
Front Oncol; 2022; 12():1099280. PubMed ID: 36605433
[TBL] [Abstract][Full Text] [Related]
10. Optical diagnostic imaging and therapy for thyroid cancer.
Shao C; Li Z; Zhang C; Zhang W; He R; Xu J; Cai Y
Mater Today Bio; 2022 Dec; 17():100441. PubMed ID: 36388462
[TBL] [Abstract][Full Text] [Related]
11. Ursolic acid inhibits proliferation, migration and invasion of human papillary thyroid carcinoma cells via CXCL12/CXCR4/CXCR7 axis through cancer-associated fibroblasts.
Cao X; He Q
Hum Exp Toxicol; 2022; 41():9603271221111333. PubMed ID: 35786050
[TBL] [Abstract][Full Text] [Related]
12. The effects of Epigallocatechin-3-gallate and Dabrafenib combination on apoptosis and the genes involved in epigenetic events in anaplastic thyroid cancer cells.
Birden N; Selvi Gunel N; Ozates NP; Goker Bagca B; Gunduz C; Sabour Takanlou L; Sabour Takanlou M; Biray Avci C
Med Oncol; 2022 May; 39(5):98. PubMed ID: 35599263
[TBL] [Abstract][Full Text] [Related]
13. The Cross-Talk between Polyphenols and the Target Enzymes Related to Oxidative Stress-Induced Thyroid Cancer.
Heydarzadeh S; Kia SK; Zarkesh M; Pakizehkar S; Hosseinzadeh S; Hedayati M
Oxid Med Cell Longev; 2022; 2022():2724324. PubMed ID: 35571253
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
